Study of CM313(SC) Injection in Systemic Lupus Erythematosus(SLE)

Clinical trial NCT06791772 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06791772
Sponsor: Keymed Biosciences Co.Ltd
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus

Start date: 2025-02-01
Primary completion: 2026-10-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.